153 related articles for article (PubMed ID: 2652547)
21. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
[No Abstract] [Full Text] [Related]
22. Triple therapy improves the survival of cadaver renal allografts affected by acute tubular necrosis.
Bakran A; Johnson RW; Dyer PA; Mallick NP; Gokal R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1278-9. PubMed ID: 2652423
[No Abstract] [Full Text] [Related]
23. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation.
Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P
Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465
[No Abstract] [Full Text] [Related]
24. Cadaver renal transplantation without maintenance steroids.
Johnson RW; Mallick NP; Bakran A; Pearson RC; Scott PD; Dyer P; Donaghue D; Morris D; Gokal R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1581-2. PubMed ID: 2652513
[No Abstract] [Full Text] [Related]
25. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
[No Abstract] [Full Text] [Related]
26. Pathology of two-year renal biopsies in cyclosporine and conventionally immunosuppressed renal transplants.
Santelli G; Hiesse C; Schovaert D; Fassi-Fihri S; Lantz O; Bensadoun H; Benoit G; Charpentier B; Martin E; Fries D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1674-6. PubMed ID: 2652548
[No Abstract] [Full Text] [Related]
27. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
[No Abstract] [Full Text] [Related]
28. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
[No Abstract] [Full Text] [Related]
29. Cyclosporine to azathioprine conversion in cadaveric renal transplants.
Gonwa TA; Nghiem DD; Corry RJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2018-20. PubMed ID: 3079068
[No Abstract] [Full Text] [Related]
30. Immunohistology or conventional histology for the diagnosis of renal allograft rejection?
McWhinnie DL; Hughes D; Fuggle SV; Dunnill MS; Carter NP; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1888-9. PubMed ID: 2652613
[No Abstract] [Full Text] [Related]
31. Elective cyclosporine conversion from triple therapy.
Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
[No Abstract] [Full Text] [Related]
32. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
[No Abstract] [Full Text] [Related]
33. Successful cadaveric renal transplantation in infants and young children.
Ettenger RB; Rosenthal JT; Marik J; Salusky IB; Kamil E; Malekzadeh MH; Fine RN
Transplant Proc; 1989 Feb; 21(1 Pt 2):1707-8. PubMed ID: 2652559
[No Abstract] [Full Text] [Related]
34. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
Pomer S; Daniel V; Dreikorn K; Röhl L
Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
[No Abstract] [Full Text] [Related]
35. Adrenal function as an index of the immunosuppressive activity of glucocorticoids (prednisolone) in renal allograft recipients.
Kozaki M; Hirano T; Oka K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2237-9. PubMed ID: 3079076
[No Abstract] [Full Text] [Related]
36. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Yoshida T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531
[No Abstract] [Full Text] [Related]
37. Cyclosporin A treatment with successful selective conversion after six months in 70 renal allograft recipients.
Venning MC; Lennard TW; Stevens ME; Proud G; Ward MK; Elliott RW; Taylor RM; Wilkinson R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1633-4. PubMed ID: 2652533
[No Abstract] [Full Text] [Related]
38. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
[No Abstract] [Full Text] [Related]
39. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
[No Abstract] [Full Text] [Related]
40. Improved immunosuppression for heart transplantation.
Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE
J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
